Neobladder and ablative pelvic radiotherapy: still a taboo?

Tumori. 2021 Jul 8:3008916211031295. doi: 10.1177/03008916211031295. Online ahead of print.ABSTRACTThe presence of a neobladder constitutes a limitation for the radiation oncologist, as there is no clear evidence about its tolerance to radiotherapy (RT). The limited literature only concerns the conventional postoperative treatment in patients with bladder cancer after cystectomy. Here we report a case of a patient with neobladder who underwent a stereotactic RT for a pelvic recurrence of disease, with response to treatment and no toxicity to the neobladder. This case represents a promising example of the chance to perform RT with ablative intent, using advanced techniques, even on lesions close to the neobladder.PMID:34235994 | DOI:10.1177/03008916211031295

Source: Tumori - July 8, 2021 Category: Cancer & Oncology Authors: Luca Bergamaschi Marianna Alessandra Gerardi Mattia Zaffaroni Matteo Augugliaro Sabrina Vigorito Elena Rondi Paolo Della Vigna Gianluca Varano Uberto Fumagalli Romario Roberto Biffi Edgardo Enrico Edoardo Picardi Annamaria Ferrari Barbara Alicja Jereczek- Source Type: research